Yarrow Bioscience (YARW) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 10 33 sessions, July 28, 2026 to September 11, 2026
- Largest daily move
- +13% close of August 4, 2026
Company Description
Yarrow Bioscience (NASDAQ: YARW) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $72.1M.
YARW has declined 37.1% over the past month. The last closing price was $27.01.
For FY2025, Yarrow Bioscience reported revenue of $570K with net income of -$26.5M and diluted earnings per share of -$0.62. The company operates at a net profit margin of -4646.1%.
This page collects what Stock Titan holds for YARW, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Yarrow Bioscience (YARW) closed at $27.01 on September 11, 2026. Over the past month, the price has lost 37.1%.
YARW Metrics & Rankings
Price returns through September 11, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Yarrow Bioscience has 4 recent news articles, with the latest published 2 days ago. Of the recent coverage, 0 articles coincided with positive price movement and 3 with negative movement. Key topics include offering, earnings, acquisition. View all YARW news →
SEC Filings
Yarrow Bioscience has filed 5 recent SEC filings, including 2 Form 424B5, 1 Form 8-K, 1 Form EFFECT, 1 Form SCHEDULE 13G. The most recent filing was submitted on September 11, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all YARW SEC filings →
Financial Highlights
Yarrow Bioscience generated $570K in revenue in FY2025, operating income reached -$29.7M (-5219.1% operating margin), and net income was -$26.5M, reflecting a -4646.1% net profit margin. Diluted earnings per share stood at -$0.62. The company generated -$33.1M in operating cash flow. With a current ratio of 12.53, the balance sheet reflects a strong liquidity position.
Upcoming Events
Offering closing
Phase 2a/2b topline data
Yarrow Bioscience has 2 upcoming scheduled events. The next event, "Offering closing", is scheduled for September 14, 2026 (tomorrow). 1 of the upcoming events are financial in nature, such as earnings calls or quarterly results. Investors can track these dates to stay informed about potential catalysts that may affect the YARW stock price.
Short Interest History
Short interest in Yarrow Bioscience (YARW) currently stands at 19.4 thousand shares, up 54.4% from the previous reporting period, representing 1.1% of the float. Since July 2026, short interest has increased by 54.4%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Yarrow Bioscience (YARW) currently stands at 1.1 days, up 12% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
YARW Company Profile & Sector Positioning
Yarrow Bioscience (YARW) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.